Section Arrow
PEN.NYSE
- Penumbra
Quotes are at least 15-min delayed:2025/01/21 05:20 EST
Last
 263.69
+1.38 (+0.53%)
Day High 
264.93 
Prev. Close
262.31 
1-M High
263.77 
Volume 
433.78K 
Bid
105.8
Ask
421.9
Day Low
259.31 
Open
264.93 
1-M Low
222.59 
Market Cap 
10.07B 
Currency USD 
P/E 301.51 
%Yield -- 
10-SMA 250.38 
20-SMA 245.66 
50-SMA 242.98 
52-W High 277.34 
52-W Low 148 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
0.87/5.01
Enterprise Value
10.29B
Balance Sheet
Book Value Per Share
28.77
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
1.06B
Operating Revenue Per Share
25.93
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed:2025/01/21 05:20 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.